Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online August 30, 2007
Stem Cells Vol. 25 No. 12 December 2007, pp. 3173 -3182
doi:10.1634/stemcells.2007-0465; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0465v1
25/12/3173    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morosetti, R.
Right arrow Articles by Ricci, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morosetti, R.
Right arrow Articles by Ricci, E.

TISSUE-SPECIFIC STEM CELLS

Isolation and Characterization of Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy Muscle Biopsies

Roberta Morosettia,b, Massimiliano Mirabellaa,b, Carla Gliubizzia,b, Aldobrando Broccolinia, Cristina Sancriccaa, Mario Pescatoria,b, Teresa Gidaroa, Giorgio Tascaa, Roberto Frusciantea, Pietro Attilio Tonalia,b, Giulio Cossuc, Enzo Riccia,b

aDepartment of Neurosciences, Catholic University School of Medicine "A. Gemelli," Rome, Italy;
bFondazione Don Carlo Gnocchi, Rome, Italy;
cStem Cells Research Center, San Raffaele Hospital, Milan, Italy

Key Words. Muscle stem cells • Mesoangioblasts • Myoblasts • Facioscapulohumeral muscular dystrophy

Correspondence: Roberta Morosetti, M.D., Department of Neurosciences, Catholic University School of Medicine, Largo A. Gemelli 8, 00168 Rome, Italy. Telephone: 39-06-30154303; Fax: 39-06-35501909; e-mail: rmorosetti{at}rm.unicatt.it; Massimiliano Mirabella, M.D., Ph.D., Department of Neurosciences, Catholic University School of Medicine, Largo A. Gemelli 8, 00168 Rome, Italy. Telephone: 39-06-30154303; Fax: 39-06-35501909; e-mail: mirabella{at}rm.unicatt.it

Received on June 14, 2007; accepted for publication on August 23, 2007.

First published online in STEM CELLS EXPRESS  August 30, 2007.


Facioscapulohumeral muscular dystrophy (FSHD) is the third most frequent inherited muscle disease. Because in FSHD patients the coexistence of affected and unaffected muscles is common, myoblasts expanded from unaffected FSHD muscles have been proposed as suitable tools for autologous cell transplantation. Mesoangioblasts are a new class of adult stem cells of mesodermal origin, potentially useful for the treatment of primitive myopathies of different etiology. Here, we report the isolation and characterization of mesoangioblasts from FSHD muscle biopsies and describe morphology, proliferation, and differentiation abilities of both mesoangioblasts and myoblasts derived from various affected and unaffected muscles of nine representative FSHD patients. We demonstrate that mesoangioblasts can be efficiently isolated from FSHD muscle biopsies and expanded to an amount of cells necessary to transplant into an adult patient. Proliferating mesoangioblasts from all muscles examined did not differ from controls in terms of morphology, phenotype, proliferation rate, or clonogenicity. However, their differentiation ability into skeletal muscle was variably impaired, and this defect correlated with the overall disease severity and the degree of histopathologic abnormalities of the muscle of origin. A remarkable differentiation defect was observed in mesoangioblasts from all mildly to severely affected FSHD muscles, whereas mesoangioblasts from morphologically normal muscles showed no myogenic differentiation block. Our study could open the way to cell therapy for FSHD patients to limit muscle damage in vivo through the use of autologous mesoangioblasts capable of reaching damaged muscles and engrafting into them, without requiring immune suppression or genetic correction in vitro.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
DMMHome page
R. D. Wuebbles, M. L. Hanel, and P. L. Jones
FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy
Dis. Model. Mech., May 1, 2009; 2(5-6): 267 - 274.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Lolmede, L. Campana, M. Vezzoli, L. Bosurgi, R. Tonlorenzi, E. Clementi, M. E. Bianchi, G. Cossu, A. A. Manfredi, S. Brunelli, et al.
Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways
J. Leukoc. Biol., May 1, 2009; 85(5): 779 - 787.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.